TABLE 1.
Demographics of respondents
| Demographics | 2008 | 2011 | P |
| N | 294 | 142 | |
| Age, y (%) | |||
| 10–12 | 50 (17) | 19 (13) | ns |
| 13–15 | 82 (28) | 36 (25) | ns |
| 16–18 | 77 (26) | 50 (35) | ns |
| 19–21 | 51 (17) | 25 (18) | ns |
| >21 | 34 (12) | 12 (9) | ns |
| Sex (%) | |||
| Male | 148 (50) | 62 (44) | ns |
| Female | 146 (50) | 80 (56) | ns |
| Diagnosis (%) | |||
| CD | 201 (68) | 96 (68) | ns |
| UC | 82 (28) | 44 (31) | ns |
| IC | 11 (3) | 2 (1) | ns |
| Duration of disease, y (%) | |||
| 3 or less | 159 (54) | 63 (44) | ns |
| >3 | 54 (46) | 79 (56) | ns |
| Medication (%) | |||
| On calcineurin inhibitors | 6 (2) | 3 (2) | ns |
| On biologics | 84 (29) | 55 (39) | ns |
| On immunomodulators | 133 (45) | 25 (18) | ns |
| On aminosalicylates | 122 (41) | 52 (37) | ns |
For each cohort the number of respondents is listed with corresponding percentages. Patients could be taking >1 medication so the percentages do not add up to 100. There are no significant differences in the cohorts in terms of age, sex, diagnosis, or duration of disease, or in medication. CD = Crohn disease; IC = indeterminate colitis; ns = not significant; UC = ulcerative colitis.